Patient Care
- Find a Doctor
  Find a doctor by specialty or location.
- Care Locations
  Find primary and specialty care near you.
- Departments and Centers
  New knowledge driving discovery to advance the health of our communities.
- Research
  Every discovery advances academic medicine and improves the vitality of our communities.
- Pay a Bill
  Pay a a bill for services performed by MCW.
- Contact
  Let us help you find an answer to your question.
- MyChart Login
  MyChart user? Log in to make an appointment.
- Request an Appointment Online
  Or call Adult Specialties (800) 272-3666 or Pediatric Specialties (877) 607-5280.
Education
- Medical School
  Choose from a three or four-year MD program at various campus locations, our anesthesiologist assistant or a number of dual degree programs.
- Graduate School
  Designed to provide a unique, specialized learning experience.
- Pharmacy School
  An innovative three-year PharmD program designed for the expanding pharmacist role in patient care.
- Residency and Fellowship Programs
  Choose from more than 140 specialties and sub-specialties for advanced medical training at MCW.
- Commencement
  MCW Commencement Events – All Campuses
Research
Community
Giving
Find a Doctor

Melissa Whyte

Home /
Education /
Graduate School /
Melissa Whyte

Melissa Whyte

Graduate Student

Locations

Microbiology & Immunology

Contact Information

mwhyte@mcw.edu

Biography

Mentor: Amy Hudson, PhD
Year Entered MCW: 2016
Previous Education: BS, University of Wisconsin-Milwaukee, Milwaukee, WI, 2014; MS, University of Wisconsin-Milwaukee, Milwaukee, WI, 2016

Research Interests

Mechanisms of viral immune evasion by human herpesvirus-6 and -7

“I am interested in pathogen-host interactions. In Dr. Hudson's lab, we study mechanisms by which human herpesvirus-6 and -7 interfere with normal cellular processes in order to evade detection by the host immune system. Our work focuses on the viral protein U21, which reroutes class I MHC to lysosomes, preventing the presentation of viral antigens to cytotoxic T lymphocytes. We are currently investigating potential U21-interacting partners as well as the trafficking pattern of U21 within host cells.”